<DOC>
	<DOCNO>NCT00553592</DOCNO>
	<brief_summary>To compare efficacy two dosage ( 600mg/day 1200mg/day ) bicifadine SR placebo 14 week reduction chronic neuropathic patin ( measure daily rating pain intensity ) associate diabetic periperal neuropathy adult outpatient . To compare tolerability two dosage bicifadine SR placebo adult outpaitens treat chronic neuropathic pain 14 week associate diabetic peripheral neuropathy .</brief_summary>
	<brief_title>Double Blind RCT Bicifadine SR Outpatients With Chronic Neuropathic Pain Associated With Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>Male female , 18 year old Diagnosis type1 type 2 noninsulin dependent diabetes mellitus Chronic bilateral pain due diabetic neuropathy Pain least six month Primary pain locate foot Otherscontact site information Symptoms painful condition Presence amputation toe Clinically significant psychiatric neurological disorder Use certain medication Clinically important disease Pregnancy History alcohol narcotic abuse within two year Otherscontact site information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2007</verification_date>
</DOC>